Login

Switch On Your HIV Smarts.

START Trial Shows Benefits of Early Treatment, Supports ART For All

START Trial Shows Benefits of Early Treatment, Supports ART For All

, by Liz Highleyman

Complete results from the START trial leave no room for doubt about benefits of early HIV treatment—and will influence development of world’s ART guidelines. Read More

ATN 110: PrEP Adherence Challenges of Young Black Gay Men

ATN 110: PrEP Adherence Challenges of Young Black Gay Men

, by Emily Newman

Researcher calls for efforts to close gap in health disparities and make PrEP feasible for young gay men of color. Read More

People with Housing and Higher HIV Risk are More Adherent to PrEP

People with Housing and Higher HIV Risk are More Adherent to PrEP

, by Emily Newman

Results from U.S. PrEP demonstration projects in San Francisco, D.C. and Miami find that adherence is correlated to two key factors. Read More

Adapting PrEP to Match Sex Patterns

Adapting PrEP to Match Sex Patterns

, by Emily Newman

The HPTN 067 study results shed light on the feasibility of non-daily PrEP dosing in three separate populations. Read More

HPTN 052: No Partner Infections with Viral Suppression

HPTN 052: No Partner Infections with Viral Suppression

, by Emily Newman

Final HPTN 052 study results reveal benefits of treatment as prevention—people with HIV can reduce their risk of HIV transmission by more than 93% with early ART. Read More